Orodispersible Films – Emerging and Patient Centric Drug Delivery System

30 November, 2021 12:00 am

Oral route is the most preferred form of drug delivery as it is easier, non-invasive, convenient, flexible and also involves low cost of production . . . . .

30 November, 2021 12:00 am

Related Articles

30 March, 2022 12:00 am

Transdermal Drug Delivery System (TDDS)
30 January, 2022 12:00 am

Formulation Development using Soft Gelatin-Based Technology
30 November, 2021 12:00 am

EU GMP Success of Jiangsu Hansoh Pharmaceutical Group Co Ltd with the support of PharmSol
30 September, 2021 12:00 am

Dry Powder Inhalers – A preferred form of inhalation therapeutic segment for respiratory diseases
30 July, 2021 12:00 am

MUPS – A Promising & Flexible Controlled Drug Delivery System
30 May, 2021 12:00 am

Excipients: From an auxiliary substance to game changer in Drug Delivery
30 December, 2020 12:00 am

Hot Melt Technology – Novel Solvent Free Approach
25 November, 2020 12:00 am

EU Regulatory requirement on Falsified Medicine Directive (FMD)
14 February, 2020 12:00 am

EU GMP Success of Finoso Pharma Private Ltd. with the support of PharmSol
14 October, 2020 12:00 am

ARE YOU BREXIT READY?
14 October, 2020 12:00 am

PharmSol is proud to be associated with Eskayef in EU GMP Success
21 July, 2020 12:00 am

Navigating Regulatory Requirements for Drug Substances
7 July, 2020 12:00 am

Drug Substances – Managing Risks
14 June, 2020 12:00 am

The Future of Pharmaceutical Contract Development
11 May, 2020 12:00 am

Challenges in the EUGMP Inspection of Sterile Facility
23 April, 2020 12:00 am

Realignment in Drug Substances – POST COVID 19
8 April, 2020 12:00 am

A Perspective on Changing Regulatory Landscape in China Pharma Industry
13 February, 2020 12:00 am

PharmSol Team Message
3 October, 2019 12:00 am

EU GMP Certification of Jiangsu Hansoh Pharmaceutical Co. Ltd. supported by PharmSol Group
15 June, 2019 12:00 am

EU GMP Certification of Shouguang Fukang Pharmaceutical Ltd. supported by PharmSol Group
20 August, 2019 12:00 am

EU GMP Certification of Beximco Pharmaceuticals Ltd. supported by PharmSol Group
14 August, 2019 12:00 am

EU GMP CERTIFICATION OF SRI KRISHNA PHARMACEUTICALS LTD. (SKPL) SUPPORTED BY PHARMSOL GROUP
18 April, 2019 12:00 am

EU GMP CERTIFICATION OF UNISON PHARMACEUTICAL PVT LTD SUPPORTED BY PHARMSOL GROUP
28 October, 2019 12:30 am

PHARMSOL NEWS ISSUE NO. 5
14 October, 2019 12:15 am

PHARMSOL NEWS ISSUE NO. 4
29 September, 2019 12:00 am

PHARMSOL NEWS ISSUE NO. 3
18 April, 2019 12:00 am

We are delighted to announce the opening of our new office located at Nanjing, China
8 March, 2018 12:00 am

EU GMP Certification of Anqui Lu’An Pharmaceutical Co. Ltd. supported by PharmSol Group
22 November, 2017 12:00 am

EU GMP Certification of Sri Krishna Pharmaceuticals Ltd. (SKPL) supported by PharmSol Group 
22 November, 2017 12:00 am

EU GMP Certification of Shouguang Fukang Pharmaceutical Co. Ltd. supported by PharmSol Group
1 February, 2018 8:00 am

PharmSol News Issue No. 1
1 March, 2018 12:00 am

PharmSol News Issue No. 2
15 January, 2017 12:00 am

EU GMP Certification of Galpha Baddi supported by PharmSol Group
19 January, 2017 12:00 am

Changzhou Yabang and PharmSol Group Strategic Alliance
22 January, 2017 12:00 am

Strategic Cooperation – Jiangsu Hansoh and PharmSol Group
26 June, 2016 12:00 am

PharmSol conducts CEIV Pharma Audit at Changi Airport (SIN)
12 October, 2016 12:00 am

DNATA, Dubai, CEIV Pharma Audit by PharmSol
7 November, 2016 12:00 am

Sinopharm Zhijun & PharmSol – Strategic Cooperation Agreement for Co-development of Products
16 November, 2016 12:00 am

PharmSol’s Presence at CEIV Pharma Audit, Hong Kong
18 August, 2016 12:00 am

Training Program at Medicines Authority, Malta
18 May, 2016 12:00 am

We are delighted to announce the opening of our new office located at Zhuhai, China
15 March, 2016 12:00 am

Successful CEIV Pharma Training